Loading organizations...
Crane Co. develops and manufactures highly engineered solutions for demanding environments across aerospace, defense, and process flow industries. The company's core offering spans two primary segments: Aerospace & Advanced Technologies, focusing on proprietary systems for mission-critical performance, and Process Flow Technologies, which delivers robust solutions for applications ranging from cryogenics and nuclear to pharmaceutical and chemical processes. Its technical approach centers on differentiated technology and proven reliability.
The company's origins trace back to July 4, 1855, when it was founded by Richard Teller Crane. His foundational principles of honesty, fairness, and deep business immersion established a culture of engineering excellence that has endured for over 170 years. This initial insight into meticulous and ethical business practice laid the groundwork for Crane Co.'s long-standing success and continuous evolution.
Crane Co. serves a broad base of industrial customers who require reliable, high-performance components in the most challenging operational contexts. The company envisions continued long-term success through a strategy built on durability, innovation, and operational discipline. Its commitment extends to making a global impact through initiatives focused on philanthropy, sustainability, and equality, reflecting a forward-looking perspective on responsible industrial leadership.
Cr has 4 tracked investments across 4 companies. The latest tracked deal is $153.0M Series E in Arthrosi Therapeutics in October 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 8, 2025 | Arthrosi Therapeutics | $153.0M Series E | Prime Eight Capital | HM Venture Partners, Relianttech |
| Nov 21, 2022 | Aniah | $6.2M Series A | Damien Bretegnier | BNP Paribas, Bpifrance |
| May 1, 2021 | Astrocyte Pharmaceuticals | $6.0M Series A | Boston Harbor Angels, Good Growth Capital | DeepWork Capital, SAM Goldberger, Astia Angels, Band OF Angels, Berkeley Angel Network, Dreamers Startup Ventures, Kyto Technology & Life Science, Life Science Angels, Mass Medical Angels, MID Atlantic BIO Angels, Portfolia, Reno Seed Fund, Sidecar Angels, Trend Investment Group, ZHI GAO Holding |
| Jul 1, 2019 | Amolyt Pharma | $74.0M Series A | LSP | Kurma Partners, Pontifax Venture Capital, Bpifrance, Novo Ventures, OrbiMed, Partners Innovation Fund, Sham Innovation Sant, TAB Consulting |